Spots Global Cancer Trial Database for Mindfulness Interventions and Cutaneous T Cell Lymphoma (CTCL)

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Mindfulness Interventions and Cutaneous T Cell Lymphoma (CTCL)

Official Title: Mindfulness Interventions and Cutaneous T Cell Lymphoma (CTCL)

Study ID: NCT03174808

Conditions

Anxiety

Quality of Life

Interventions

Mindfulness-Based Stress Reduction (MBSR)

Study Description

Brief Summary: The primary objective is to assess the feasibly, adherence, and effects of mindfulness-based stress reduction (MBSR) on anxiety and health-related quality of life in adult patients with cutaneous T-cell lymphoma at the Yale Cancer Center/Smilow Cancer Hospital. Participants will attend group sessions led by an instructor experienced in MBSR in an academic setting. The mindfulness meditation group sessions will take place at the Smilow Cancer Center at the Yale New-Haven Hospital.

Detailed Description: Participants will attend weekly 2.5-hour group sessions (of 10-14 persons) based on the standard mindfulness-based stress reduction (MBSR) protocol. Participants will be assigned home practice based on the MBSR protocol, and will be given audio recordings (MP3) to accompany and instruct in home practice. Eligible participants will attend weekly group sessions for 8 weeks and will be assessed at baseline, following cessation of the intervention (8-weeks), and 16 weeks. Outcomes will be assessed at baseline, 8 weeks, and 16 weeks. Extended effects of the intervention will be assessed at 16 weeks.